AHA: Adding Omega-3 Fatty Acids Does Not Cut High CV Risk
THURSDAY, Nov. 19, 2020 -- A carboxylic acid formulation of eicosapentaenoic acid and docosahexaenoic acid (omega-3 CA) does not improve outcomes among statin-treated patients at high cardiovascular risk, according to a study published online Nov....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Cardiovascular | Cholesterol | Heart | Omega 3 | Pharmaceuticals | Statin Therapy | Study